Evidence map›Paper›PMID 31036919›Full record

ArticleNature reviews. Microbiology2019

Publisher Correction: Definitions and guidelines for research on antibiotic persistence.

Nathalie Q Balaban, Sophie Helaine, Kim Lewis, Martin Ackermann, Bree Aldridge, Dan I Andersson, Mark P Brynildsen, Dirk Bumann, Andrew Camilli, James J Collins and 15 more

Abstract readPublished Erratum
In one paragraph

Article in Nature reviews. Microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Netupitant Exhibits Potent Activity onACS infectious diseases · 2025
    Article
  4. Review
  5. Article
  6. The Evolution of Heteroresistance via Small Colony Variants inbioRxiv : the preprint server for biology · 2024
    Article
  7. Characterization ofMicroorganisms · 2024
    Article
  8. Antimicrobial agents and chemotherapy · 2024
    Article
  9. Itaconate induces tolerance ofFrontiers in microbiology · 2024
    Article
  10. Microbiology spectrum · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Environmental Spread of Antibiotic Resistance.Antibiotics (Basel, Switzerland) · 2021
    Review
  15. Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy ofProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Nathalie Q BalabanRacah Institute of Physics, The Hebrew University, Jerusalem, Israel. nathalie.balaban@mail.huji.ac.il.ORCID http://orcid.org/0000-0001-8018-0766
Sophie HelaineMRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-9877-4180
Kim LewisDepartment of Biology, Northeastern University, Boston, MA, USA.
Martin AckermannInstitute of Biogeochemistry and Pollutant Dynamics, ETH Zurich, Zurich, Switzerland.
Bree AldridgeDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA.
Dan I AnderssonDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0001-6640-2174
Mark P BrynildsenDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, USA.
Dirk BumannFocal Area Infection Biology, Biozentrum of the University of Basel, Basel, Switzerland.
Andrew CamilliDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA.
James J CollinsInstitute for Medical Engineering & Science, Department of Biological Engineering, and Synthetic Biology Center, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-5560-8246
Christoph DehioFocal Area Infection Biology, Biozentrum of the University of Basel, Basel, Switzerland.
Sarah FortuneDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7565-9975
Jean-Marc GhigoInstitut Pasteur, Genetics of Biofilms Laboratory, Paris, France.
Wolf-Dietrich HardtInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Alexander HarmsFocal Area Infection Biology, Biozentrum of the University of Basel, Basel, Switzerland.
Matthias HeinemannMolecular Systems Biology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, Netherlands.ORCID http://orcid.org/0000-0002-5512-9077
Deborah T HungBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Urs JenalFocal Area Infection Biology, Biozentrum of the University of Basel, Basel, Switzerland.
Bruce R LevinDepartment of Biology, Emory University, Atlanta, GA, USA.
Jan MichielsCenter for Microbiology, KU Leuven-University of Leuven, Leuven, Belgium.
Gisela StorzDivision of Molecular and Cellular Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA.
Man-Wah TanInfectious Diseases Department, Genentech, South San Francisco, CA, USA.
Tanel TensonInstitute of Technology, University of Tartu, Tartu, Estonia.
Laurence Van MelderenFaculté des Sciences, Université Libre de Bruxelles, Bruxelles, Belgium.
Annelies ZinkernagelDivision of Infectious Diseases, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Funding

Medical Research Council MR/P028225/1
6 · The paper itself

Abstract

In Figure 2b, the minimal duration for killing (MDK) 99% of tolerant cells was erroneously labelled as MDK99.99 instead of MDK99. This has now been corrected in all versions of the Review. The publisher apologizes to the authors and to readers for this error.

Identifiers

PMID31036919
PMCPMC7609342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.